Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Blocklisting cancellation and interim review

7 May 2026 11:45

RNS Number : 4468D
Thruvision Group PLC
07 May 2026
 

7 May 2026

 

Thruvision Group plc

("Thruvision" or the "Company")

 

Blocklisting cancellation and interim review

 

Thruvision (AIM:THRU, "Thruvision" or the "Group"), a leading international provider of walk-through security technology, today announces an update to its blocklisting application. No further shares will be allotted pursuant to this block listing application and a final block listing return is set out below.

 

Name of Company:

 

Thruvision Group plc

Name of Scheme:

 

Thruvision Group plc Long Term Incentive Plan

Period of return:

 

6 November 2025 to 6 May 2026

Balance of Ordinary 1p shares under the Scheme at 6 November 2025:

 

1,950,626

 

Number of Ordinary 1p shares issued under the Scheme during the period:

 

Nil

Number of options under the scheme that have lapsed during the period:

 

Nil

Balance of Ordinary 1p shares under the Scheme at 6 May 2026:

 

1,950,626

 

This is the final return. No further shares will be allotted pursuant to this block listing.

 

At 6 May 2026 the total number of Ordinary Shares in issue with voting rights is 448,559,010.

 

No Ordinary Shares are held in treasury.

 

The above figure of 448,559,010 Ordinary Shares in the Company carrying voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Thruvision Group plc +44 (0)12 3542 5400

Victoria Balchin, Chief Executive Officer

 

Allenby Capital Limited (NOMAD & Broker) +44 (0)20 3328 5656

James Reeve

 

About Thruvision (www.thruvision.com)

Thruvision is a leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 30 countries around the world by government and commercial organisationsin a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group's offices are near Oxford and Washington DC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSIELIDIIR
Date   Source Headline
14th May 20267:00 amRNS-RNew Strategic Partnerships
7th May 202611:45 amRNSBlocklisting cancellation and interim review
7th May 202611:45 amRNSBlocklisting cancellation and interim review
8th Apr 20267:00 amRNSFY26 Trading Update
13th Mar 20267:00 amRNSUS Aviation Contract Award
13th Mar 20267:00 amRNSUS Aviation Contract Award
19th Feb 20267:00 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSContract awards into UK custodial facilities
12th Feb 20267:00 amRNS-RFirst UK “Screening as a Service” Sales
22nd Jan 20267:00 amRNS-RUK Retail Distribution Contract Award
20th Jan 20267:00 amRNSSouth-East Asian Mass Transit Contract Award
12th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 202611:27 amRNSAward of Share Options
19th Dec 20251:07 pmRNS-RUS Retail Distribution Contract Award
19th Dec 20251:07 pmRNS-RUS Retail Distribution Contract Award
16th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20257:00 amRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RImminent contract award
4th Dec 20257:00 amRNSHolding(s) in Company
28th Nov 20253:45 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSHolding(s) in Company
25th Nov 20257:00 amRNSInterim Results and Trading Update
6th Nov 20254:30 pmRNSBlock listing Interim Review
6th Nov 20254:30 pmRNSBlock listing Interim Review
23rd Oct 202510:53 amRNSResult of AGM
23rd Oct 20257:00 amRNSAGM Statement and Trading Update
6th Oct 20251:49 pmRNS-RNPSA Testing Update
30th Sep 202512:33 pmRNSHolding(s) in Company
29th Sep 202512:04 pmRNSHolding(s) in Company
29th Sep 202511:26 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
19th Sep 20257:00 amRNSFinal Results
15th Sep 202512:40 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNS-RAdditions to Value-Added Reseller Network
1st Aug 20259:46 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSHolding(s) in Company
31st Jul 20255:00 pmRNSTotal Voting Rights
31st Jul 20252:37 pmRNSHolding(s) in Company
31st Jul 20252:01 pmRNSHolding(s) in Company
31st Jul 202510:32 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHolding(s) in Company
29th Jul 20251:54 pmRNSHolding(s) in Company
28th Jul 202510:50 amRNSResult of GM and completion of Capital Raising
28th Jul 20257:00 amRNSChange of Adviser
8th Jul 20257:00 amRNSResult of Retail Offer & Notice of General Meeting
4th Jul 20257:05 amRNSWRAP Retail Offer
4th Jul 20257:00 amRNSResult of Review & Proposed Capital Raise
2nd Jul 20257:00 amRNSMaterial Contract Award and Trading Update
23rd Jun 20251:50 pmRNSHolding(s) in Company
23rd Jun 20257:00 amRNSUpdate on Strategic Review and Formal Sale Process

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.